Ex Vivo News and Research

RSS
USPTO grants four key patents for Alvine's proteases to detect celiac disease

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Atox Bio completes AB103 phase 1 study in severe bacterial infections and sepsis

Atox Bio completes AB103 phase 1 study in severe bacterial infections and sepsis

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

RTCA HT instrument from Roche employs high-throughput real-time cell analysis

RTCA HT instrument from Roche employs high-throughput real-time cell analysis

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Generex, Antigen Express and RXi report positive research data from active immunotherapy collaboration

Generex, Antigen Express and RXi report positive research data from active immunotherapy collaboration

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros receives exclusive license for new series of antifibrinolytic agents

John Theurer Cancer Center presents research findings at ASH meeting

John Theurer Cancer Center presents research findings at ASH meeting

Arteriocyte launches Stem Cell Expansion System for research use

Arteriocyte launches Stem Cell Expansion System for research use

miRagen and t2cure enter licensing agreement for microRNA 92 technology

miRagen and t2cure enter licensing agreement for microRNA 92 technology

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

POZEN presents PA32540 Phase 1 study results for cardiovascular disease at AHA Session

POZEN presents PA32540 Phase 1 study results for cardiovascular disease at AHA Session

NexBio presents Fludase data for Influenza-Like Illness at ACAAI 2010

NexBio presents Fludase data for Influenza-Like Illness at ACAAI 2010

Mesoblast broadens cancer indications for bone marrow transplant product

Mesoblast broadens cancer indications for bone marrow transplant product

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.